Get to know us
EPTRI is a new enstablishing Research Infrastructure aiming to promote the paediatric research and provide optimal support to facilitate the accruing of knowledge in the many research fields necessary to guaranteeing the access to high quality and safe paediatric medicines
To increase knowledge on children growth and ontogeny characteristics relevant for the identification and development of novel therapies dedicated to children
To facilitate basic, preclinical, and translational research in paediatric medicines, providing access to key technologies, standardised models and analytical tools specific for children
In clinical practice, patients are often prescribed more than one drug which can result in a drug-drug interaction (DDI). The European Medicines...
The Heads of Medicines Agencies - European Medicines Agency (HMA - EMA) Big Data Steering Group is organizing the 3rd EU Big Data Stakeholders Forum...
The European Medicines Agency (EMA) has launched a pilot project to i) assess whether the analysis of ‘raw data’ from clinical trials by regulatory...